-
Clover Health Provides Business Update and Issues Partial Guidance for Full-Year 2023
Clover Wellbeing Investments, Corp. FRANKLIN, Tenn., Jan. 10, 2023 (World NEWSWIRE) — Clover Wellness Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a doctor enablement firm dedicated to bringing accessibility to excellent health care to every person on Medicare, right now supplies a business update and announces partial assistance for comprehensive-calendar year 2023. “2023 will be a pivotal calendar year for Clover Wellness and I think we will show out the power of our solution to taking care of care for Medicare beneficiaries. It’s an interesting time for me to changeover into the part of Chief Government Officer, operating with our crew to deliver final results for our…
-
Acorda Therapeutics Provides Long-Term Business Plan and Financial Guidance
PEARL RIVER, N.Y.–(Enterprise WIRE)–Acorda Therapeutics, Inc. (Nasdaq: ACOR) these days delivered a thorough, lengthy-time period business enterprise system to travel shareholder worth and also supplied prolonged-expression monetary steering. Acorda has made a extensive-term small business strategy to enhance the worth of the Company, focused on escalating INBRIJA® (levodopa inhalation powder), maximizing AMPYRA® (dalfampridine), and implementing supplemental operational and producing efficiencies. Thanks to the recent Alkermes arbitration award, together with continued fiscal discipline, Acorda has sizeable liquidity, which the Business expects will let it to execute on its enterprise program. Acorda expects to be funds-move good in 2023. The end result of the reverse inventory break up proposal at the upcoming…
Devoted to Good Business
